In terms of tumor response, the ORR was similar for the doublet plus BEV (n = 84) and doublet plus EGFR (n = 111) groups, with 67.9% (57/84) and 68.4% (76/111), respectively. The gene discussed is EGFR; the disease is neoplasm.